Notably, reduced BIN1 expression in human-induced glutamatergic neurons is sufficient to elicit gene expression alterations that are also present in AD and converge to biological processes related with calcium homeostasis and synaptic transmission. This evidence concerns the gene BIN1 and Alzheimer disease.